Eyenuk, Inc.

09/30/2026

❗ TODAY, Sept 30: How can your organization capture its share of the $50B Rural Health Transformation Program?

👉 Join us live at 5pm PT | 8pm ET for an expert conversation about using RHTP funding and autonomous AI to bring sight-saving eye care closer to rural patients.

Meet the panel:
🔹 Catherine Cohen, government relations and public policy expert (and former VP at the American Academy of Ophthalmology)
🔹 Lauren Choi, JD, health IT and regulatory compliance expert
🔹 Brianna Walker, clinical supervisor, MaineHealth

👉 **Register now - Link in first comment**

Bring your questions for the live Q&A.

09/29/2026

We go live in 24 hours!

If your health system is looking to leverage the $50 Billion Rural Health Transformation Program (RHTP) and autonomous AI to modernize ophthalmic care delivery, don't miss tomorrow's live webinar.

Featured Panelists:
🔹 Catherine Cohen - Government Relations & Public Policy Expert
🔹 Lauren Choi, JD - Health IT & Regulatory Compliance Expert
🔹 Brianna Walker - Clinical Supervisor, MaineHealth

📍 When: Tomorrow, Sept 30 @ 5pm PT | 8pm ET
👉 Register here: https://us06web.zoom.us/webinar/register/WN_p7tTmWtQRbSGWaNyXB74tA #/registration

10/21/2025

San Ysidro Health is proud to be a leader in the concept, design and implementation of a clinical trial advancing health for all through AI-powered diabetic retinopathy screening.

The Diabetic Retinopathy Screening Point of Care AI (DRES-POCAI) study, being conducted at two SYHealth clinics sites, explores how integrating artificial intelligence into primary care workflows can improve screening rates, early detection, and timely referrals for patients with diabetes, especially in historically underserved communities.

This innovative approach uses AI to analyze retinal images at the point of care, with results instantly available in electronic health records, helping streamline care and reduce barriers to vision-saving treatment.

Congratulations to our incredible San Ysidro Health staff who are leading this important work and publication alongside their teams who supported the data collection that made it possible! We’re also deeply grateful to our amazing academic and technology partners for their collaboration.

Together, leadership, innovation, and expertise are helping shape the future of healthcare!

UC San Diego Health Eyenuk, Inc.

06/13/2024

We extend our sincere gratitude to Kaushal Solanki, PhD, Founder and CEO of Eyenuk, for his unwavering commitment and vision over the past 14 years. Kaushal's leadership has been instrumental in building Eyenuk from the ground up, creating a formidable platform of AI-driven products and solutions that are now used in over 18 countries across 5 continents.

His dedication to our mission of eliminating preventable blindness has inspired us all. The contributions have not only advanced our technology but also built a strong, dedicated team and an impressive client base. We are proud of what we have achieved together and look forward to his continued support as a special advisor and board member.

As we welcome Paul Praino as our Interim CEO, we are confident that Eyenuk will continue to thrive and innovate, building on the remarkable foundation Kaushal has laid.

Thank you, Kaushal, for your visionary leadership and for taking Eyenuk to where it is today. Here's to continued success and impactful advancements of the organization in innovating healthcare for all.

/PRNewswire/ -- Eyenuk, a global artificial intelligence (AI) digital health company and leader in real-world applications for AI Eye Screening™ and AI...

02/28/2024

Congratulations to Vision Loss Rehabilitation Canada (VLRC) for their remarkable achievement in being announced a winner in the HLTH Foundation's Techquity for Health Case Study Competition and for receiving the esteemed Global Techquity Impact Award! This recognition highlights VLRC's innovative diabetic retinopathy screening program utilizing the EyeArt® Artificial Intelligence Eye Screening System by Eyenuk for individuals at risk for diabetic retinopathy, which is the leading cause of blindness among working-age adults.

The Global Techquity Impact Award was issued after reviewing over 200 case study submissions from around the world and recognizes a project outside the USA that effectively uses technology to overcome geographical, cultural, or socioeconomic barriers for a population experiencing persistent health disparities.

By implementing the EyeArt® technology into their screening program, VLRC is pioneering advancements in enhancing access to crucial vision care, especially in underserved areas like rural, remote, and Indigenous communities throughout Ontario.

Read more about the incredible work being done by VLRC here: https://www.prnewswire.com/news-releases/hlth-foundation-honors-vision-loss-rehabilitation-canada-for-advancing-ai-enabled-healthcare-in-underserved-communities-302073778.html

Once again, a heartfelt congratulations to VLRC for this well-deserved honor!

/PRNewswire/ -- Vision Loss Rehabilitation Canada (VLRC), Canada's leading provider of rehabilitation therapy and healthcare services for individuals with...

02/02/2024

Exciting news! We are thrilled to announce that Kaushal Solanki, the Founder & CEO of Eyenuk, will be a keynote speaker at the esteemed Final Eyes CE 2024 event in St. Augustine, FL. Join us as we delve into the fascinating topic of "Harnessing Artificial Intelligence to Create a New Diagnostic Standard Using Retinal Imaging." Be prepared for groundbreaking insights and stay ahead of the curve in eye care innovation.

Make sure to mark your calendars and set your reminders for this not-to-be-missed session, starting Saturday, February 3rd at 4:40pm ET. See you there!

https://finaleyesce.com/

Don't forget to follow our page for more updates and industry insights.

FinalEyes CE is one expression of Florida Eye Cares' commitment to eye care. Educating and advancing eye care in NE Florida.

01/19/2024

Eyenuk is excited to partner with San Ysidro Health as part of the Kaiser Permanente Augmented Intelligence in Medicine and Healthcare Initiative (AIM-HI) to bring the EyeArt AI Eye Screening technology into their institution and patient community. This collaboration aims to close care gaps and provide broader access to patients. San Ysidro Health, one of the grant recipients, is focusing on point-of-care diabetic retinopathy screening using artificial intelligence. The grants, supported by the Gordon and Betty Moore Foundation, will enable research projects implementing AI and machine learning algorithms to enhance diagnostic decision-making in healthcare. The AIM-HI program, led by the Kaiser Permanente Northern California Division of Research, aims to rigorously evaluate the implementation of these technologies in diverse, real-world settings.

https://divisionofresearch.kaiserpermanente.org/kaiser-permanente-ai-machine-learning-in-health-care/
https://www.syhealth.org/
https://www.eyenuk.com/products/eyeart/

The Kaiser Permanente Augmented Intelligence in Medicine and Healthcare Initiative (AIM-HI) Coordinating Center awarded 5 health care organizations with funding to pursue research projects deploying artificial intelligence and machine learning algorithms to enhance diagnostic decision-making in heal...

11/29/2023

Artificial Intelligence (AI) has immense potential in revolutionizing the detection and monitoring of diseases through ocular imaging, promising unprecedented levels of access and precision. Yet, an industry-wide challenge persists: the lack of standardization across ocular imaging data from different device manufacturers, inhibiting seamless interoperability between diverse systems. This limitation affects our ability to enhance quality, accessibility, and equity in healthcare.

Recognizing this, the National Eye Institute (NEI), U.S. Food and Drug Administration (FDA), and the Office of the National Coordinator for Health Information Technology (ONC) convened a workshop in May 2022. The event brought together industry leaders, including Dr. Kaushal Solanki, CEO and Founder of Eyenuk. As an outcome of this collaborative effort, these federal agencies have unveiled a detailed roadmap this month promoting the adoption of standardized imaging data.

Eyenuk is proud to have contributed to this pivotal initiative. We believe in the power of interoperability, and we're excited to continue playing a part in shaping a future where ocular imaging data is standardized, promoting efficiency, enhancing access and improving patient care.

Learn more here: https://www.eyenuk.com/articles/news/eyenuk-supports-national-img-standards/

LOS ANGELES, November 28th, 2023 – Eyenuk, Inc., a leading global digital health company specializing in artificial intelligence (AI), today stands shoulder to shoulder with the National Eye Institute (NEI), U.S. Food and Drug Administration